GSK plc Share Buyback Transaction

SEC Filing 6-K (0001654954-25-008795)

GSK plc announced the purchase of 474,100 of its ordinary shares on 31 July 2025 as part of its existing buyback program. The shares were purchased through Merrill Lynch International, with prices ranging from 1,404.50p to 1,461.00p per share, and a volume-weighted average price of 1,423.11p. Following this transaction, GSK will hold 237,044,421 ordinary shares in treasury and have 4,078,340,989 ordinary shares in issue. The total number of voting rights in the Company is 4,078,340,989, with 5.81% of voting rights attributable to the treasury shares. Detailed information on the trades can be found on the London Stock Exchange and CBOE Europe Limited websites.